Sharyn N. Lewin, MD, discusses the importance of screening patients with ovarian cancer for a BRCA mutation.
Legislative Changes and Their Impact on Community Oncology Care
In an interview with Targeted Oncology, Ben Jones identified the key challenges community oncologists are facing due to legislative changes in cancer care policy.
Read More
The Future of Breast Cancer Care: Blackwood on Personalized Approaches
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.
Listen
To Detect More Alterations, Consider Adding Companion Testing to NGS
Druggable gene aberrations and predictive biomarkers has allowed for the use of next-generation sequencing technologies to grow.
Advancing the Treatment of Cervical and Endometrial Cancers
In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.
Improving Identification Within Asian American Subgroups With Ovarian Cancer
Sarah Lee, MD, MBA, discussed a study to better disaggregate the subgroup of Asian American patients with ovarian cancer.
Global Phase 3 Trial Investigates mRNA Vaccine for Melanoma Treatment
Jeff Yorio, MD, discussed the unmet needs among patients with melanoma and plans for a phase 3 study assessing an mRNA vaccine.